dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
loravis 50 microgram/ml eye drops, solution
zaklady farmaceutyczne polpharma s.a. - latanoprost - eye drops, solution - latanoprost
vardenafil inovamed 10 mg
inovamed ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 10 mg - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for vardenafil inovamed to be effective, sexual stimulation is required. not indicated for use by women
vardenafil inovamed 20 mg
inovamed ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 20 mg - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for vardenafil inovamed to be effective, sexual stimulation is required. not indicated for use by women
vardenafil inovamed 5 mg
inovamed ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 5 mg - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for vardenafil inovamed to be effective, sexual stimulation is required. not indicated for use by women
linezolid polpharma 2mg/ml, oplossing voor infusie
beclometasone/formoterol polpharma 100 mikrogramm/6 mikrogramm pro sprühstoß druckgasinhalation, lösung
citalopram teva 20 mg
teva israel ltd - citalopram as hydrobromide - film coated tablets - citalopram as hydrobromide 20 mg - for the treatment of states of depression and panic disorder.
ticagrelor inovamed 60 mg
inovamed pharma ltd, israel - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor inovamed , co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event. limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.